Covaxin neutralises double mutant strain of SARS-CoV-2: ICMR study
Covaxin neutralises double mutant strain of SARS-CoV-2: ICMR study
Indian Express
0 shares
1 views
You might like
Related news coverage
Covaxin neutralises double mutant strain, effective against multiple variants of SARS-CoV-2: ICMR
DNA
Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries..